NCT02099981View on ClinicalTrials.gov

Restoration of Retinal Vascular Responses in Type 1 Diabetic Patients

PHASE1CompletedINTERVENTIONAL
Enrollment

34

Participants

Timeline

Start Date

July 31, 2016

Primary Completion Date

December 31, 2017

Study Completion Date

December 31, 2017

Conditions
Diabetic Retinopathy
Interventions
DRUG

Aminoguanidine

Trial Locations (1)

55455

University of Minnesota Medical Center Fairview, Minneapolis

All Listed Sponsors
lead

University of Minnesota

OTHER

NCT02099981 - Restoration of Retinal Vascular Responses in Type 1 Diabetic Patients | Biotech Hunter | Biotech Hunter